Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Augustin, Regina ^a   Endres, Kristina ^b   Reinhardt, Sven ^b   Kuhn, Peer Hendrik ^c   Lichtenthaler, Stefan F ^c   Hansen, Jens ^a   Wurst, Wolfgang ^a,c,d   Trümbach, Dietrich ^a,d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; MICRORNA; MICRORNA 103; MICRORNA 107; MICRORNA 1306; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC CONSERVATION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; REPORTER GENE; RNA BINDING;

3' UNTRANSLATED REGIONS; ADAM PROTEINS; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; HUMANS; LUCIFERASES; MEMBRANE PROTEINS; MICRORNAS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 84861017904     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-35     Document Type: Article

References (60)

1. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009, 21:452-460. 10.1016/j.ceb.2009.04.009, 19450959.
2. Vasudevan S, Steitz JA. AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell 2007, 128:1105-1118. 10.1016/j.cell.2007.01.038, 3430382, 17382880.
3. Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19:92-105. 2612969, 18955434.
4. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379. 10.1146/annurev-biochem-060308-103103, 20533884.
5. Hébert SS, De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 2009, 32:199-206. 10.1016/j.tins.2008.12.003, 19268374.
6. Satoh J. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains. J Pharmacol Sci 2010, 114:269-275. 10.1254/jphs.10R11FM, 20953120.
7. Crews L, Rockenstein E, Masliah E. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Brain Struct Funct 2010, 214:111-126. 10.1007/s00429-009-0232-6, 2847155, 20091183.
8. Cole SL, Vassar R. The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology. J Biol Chem 2008, 283:29621-29625. 10.1074/jbc.R800015200, 2662048, 18650431.
9. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci 1999, 96:3922-3927. 10.1073/pnas.96.7.3922, 22396, 10097139.
10. Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 2010, 29:3020-3032. 10.1038/emboj.2010.167, 2944055, 20676056.
11. Lichtenthaler SF, Haass C, Steiner H. Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing. J Neurochem 2011, 117:779-796. 10.1111/j.1471-4159.2011.07248.x, 21413990.
12. Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M, Flamez P, Dequenne A, Godaux E, van Leuven F, Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 2004, 113:1456-1464. 406531, 15146243.
13. Watanabe Y, Tomita M, Kanai A. Computational methods for microRNA target prediction. Methods Enzymol 2007, 427:65-86.
14. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. 10.1016/j.cell.2004.12.035, 15652477.
15. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158. 10.1093/nar/gkn221, 2238936, 17991681.
16. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008, 36:D149-D153. 2238905, 18158296.
17. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
18. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39:1278-1284. 10.1038/ng2135, 17893677.
19. Miranda KC, Huynh T, Tay Y, Ang Y-S, Tam W-L, Thomson AM, Lim B, Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006, 126:1203-1217. 10.1016/j.cell.2006.07.031, 16990141.
20. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG. The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 2009, 37:D155-D158. 10.1093/nar/gkn809, 2686456, 18957447.
21. Witkos TM, Koscianska E, Krzyzosiak WJ. Practical Aspects of microRNA Target Prediction. Curr Mol Med 2011, 11:93-109. 10.2174/156652411794859250, 3182075, 21342132.
22. Zuker M, Stiegler P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 1981, 9:133-148. 10.1093/nar/9.1.133, 326673, 6163133.
23. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517. 10.1261/rna.5248604, 1370637, 15383676.
24. Krüger J, Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 2006, 34:W451-W454. 10.1093/nar/gkl243, 1538877, 16845047.
25. Wuchty S, Fontana W, Hofacker IL, Schuster P. Complete suboptimal folding of RNA and the stability of secondary structures. Biopolymers 1999, 49:145-165. 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.0.CO;2-G, 10070264.
26. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS. MicroRNA targets in Drosophila. Genome Biol 2003, 5:R1. 10.1186/gb-2003-5-1-r1, 395733, 14709173.
27. Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008, 14:27-41.
28. Bult CJ, Eppig JT, Kadin JA, Richardson JE, Blake JA, . Mouse Genome Database Group The Mouse Genome Database (MGD): mouse biology and model systems. Nucleic Acids Res 2008, 36:D724-D728. 2238849, 18158299, Mouse Genome Database Group.
29. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948. 10.1093/bioinformatics/btm404, 17846036.
30. Goujon M, McWilliam H, Li W, Valentin F, Squizzato S, Paern J, Lopez R. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res 2010, 38:W695-W699. 10.1093/nar/gkq313, 2896090, 20439314.
31. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 2007, 39:17-23. 10.1038/ng1934, 17192785.
32. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene Ontology: tool for the unification of biology. Nat Genet 2000, 25:25-29. 10.1038/75556, 3037419, 10802651.
33. Sethupathy P, Megraw M, Hatzigeorgiou AG. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Meth 2006, 3:881-886.
34. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q. An analysis of human microRNA and disease associations. PLoS One 2008, 3:e3420. 10.1371/journal.pone.0003420, 2559869, 18923704.
35. Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, Evans MK. microRNA expression patterns reveal differential expression of target genes with age. PLoS One 2010, 5:e10724. 10.1371/journal.pone.0010724, 2873959, 20505758.
36. Wang WX, Huang Q, Hu Y, Stromberg AJ, Nelson PT. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 2011, 121:193-205. 10.1007/s00401-010-0756-0, 3073518, 20936480.
37. Yao J, Hennessey T, Flynt A, Lai E, Beal MF, Lin MT. MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 2010, 5:e15546. 10.1371/journal.pone.0015546, 3002958, 21179570.
38. Wang WX, Rajeev BW, Stromberg AJ, Ren N, Tang G, Huang Q, Rigoutsos I, Nelson PT. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008, 28:1213-1223. 10.1523/JNEUROSCI.5065-07.2008, 2837363, 18234899.
39. Augustin R, Lichtenthaler SF, Greeff M, Hansen J, Wurst W, Trümbach D. Bioinformatics identification of modules of transcription factor binding sites in Alzheimer's disease-related genes by in silico promoter analysis and microarrays. International Journal of Alzheimer's Disease 2011, 2011:154325.
40. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 2007, 39:380-385. 10.1038/ng1969, 3008549, 17259983.
41. Evers LJ, Vermaak MP, Engelen JJ, Curfs LM. The velocardiofacial syndrome in older age: dementia and autistic features. Genet Couns 2006, 17:333-340.
42. Nixon RA, Saito KI, Grynspan F, Griffin WR, Katayama S, Honda T, Mohan PS, Shea TB, Beermann M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease. Ann N Y Acad Sci 1994, 747:77-91.
43. Mattson MP. ER calcium and Alzheimer's disease: in a state of flux. Sci Signal 2010, 3:pe10. 10.1126/scisignal.3114pe10, 3091478, 20332425.
44. Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 2009, 46:1241-1249. 10.1016/j.freeradbiomed.2009.02.006, 2673453, 19245828.
45. Kim D, Tsai LH. Bridging physiology and pathology in AD. Cell 2009, 137:997-1000. 10.1016/j.cell.2009.05.042, 19524503.
46. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010, 5:e10615. 10.1371/journal.pone.0010615, 2868896, 20485546.
47. Parra P, Serra F, Palou A. Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS One 2010, 5:e13005. 10.1371/journal.pone.0013005, 2946340, 20886002.
48. Liu Y, Yang L, Conde-Knape K, Beher D, Shearman MS, Shachter NS. Fatty acids increase presenilin-1 levels and gamma-secretase activity in PSwt-1 cells. J Lipid Res 2004, 45:2368-2376. 10.1194/jlr.M400317-JLR200, 15375184.
49. Wang WX, Wilfred BR, Madathil SK, Tang G, Hu Y, Dimayuga J, Stromberg AJ, Huang Q, Saatman KE, Nelson PT. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 2010, 177:334-345. 10.2353/ajpath.2010.091202, 2893676, 20489155.
50. Xie H, Lim B, Lodish HF. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009, 58:1050-1057. 10.2337/db08-1299, 2671055, 19188425.
51. Liao Y, Lönnerdal B. Global microRNA characterization reveals that miR-103 is involved in IGF-1 stimulated mouse intestinal cell proliferation. PLoS One 2010, 5:e12976. 10.1371/journal.pone.0012976, 2944884, 20886090.
52. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K, Akiyama T. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J Biol Chem 1995, 270:23031-23037. 10.1074/jbc.270.39.23031, 7559442.
53. Wines-Samuelson M, Handler M, Shen J. Role of presenilin-1 in cortical lamination and survival of Cajal-Retzius neurons. Dev Biol 2005, 277:332-346. 10.1016/j.ydbio.2004.09.024, 15617678.
54. Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 2005, 25:6887-6897. 10.1523/JNEUROSCI.5291-04.2005, 16033898.
55. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, Cimmino A, Wang H, Sun H, Volinia S, Alder H, Calin GA, Liu CG, Andreeff M, Croce CM. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 2007, 26:4148-4157. 10.1038/sj.onc.1210186, 17260024.
56. Das Neves L, Duchala CS, Godinho F, Haxhiu MA, Colmenares C, Macklin WB, Campbell CE, Butz KG, Gronostajski RM. Disruption of the murine nuclear factor I-A gene (Nfia) results in perinatal lethality, hydrocephalus, and agenesis of the corpus callosum. Proc Natl Acad Sci 1999, 96:11946-11951. 10.1073/pnas.96.21.11946, 18392, 10518556.
57. Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Moller H-J, Rapoport SI, Hampel H. Progression of corpus callosum atrophy in Alzheimer disease. Arch Neurol 2002, 59:243-248. 10.1001/archneur.59.2.243, 11843695.
58. Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D, Lowenstein CJ. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci 2010, 107:6334-6339. 10.1073/pnas.0911082107, 2851979, 20308559.
59. Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP. Vascular endothelial growth factor gene variability is associated with increased risk for AD. Ann Neurol 2005, 57:373-380. 10.1002/ana.20390, 15732116.
60. Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K. MicroRNA-122 inhibits tumorigenic properties of pepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 2009, 284:32015-32027. 10.1074/jbc.M109.016774, 2797273, 19726678.